China has approved early-stage human tests for two experimental vaccines to combat the new coronavirus that killed over 100,000 people worldwide, state media Xinhua reported on Tuesday.
For more coronavirus news, visit our dedicated page.
The vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech , and by the Wuhan Institute of Biological Products, an affiliate of state-owned China National Pharmaceutical Group.
In March, China have the green-light for another clinical trial for a coronavirus vaccine candidate developed by military-backed China’s Academy of Military Medical Sciences and HK-listed biotech firm CanSino Bio, shortly after US drug developer Moderna said it had begun human tests for their vaccine with the US National Institutes of Health.
Also Read
-
US company to use virus-like protein nanoparticles as vaccine against coronavirus
US biotechnology company Ufovax extended its patented one component self-assembling protein nanoparticle (1c-SApNP) vaccine platform technology to a ... Coronavirus -
A billion doses of coronavirus vaccine by Q4 2021 if everything goes well: US expert
One billion doses of a coronavirus vaccine could be available by the end of next year, if everything goes to plan, according to Dr. Ezekiel J. Emanuel ... World News -
Russian experts to speed up tests of coronavirus vaccines on humans
The head of a top Russian research center told President Vladimir Putin on Tuesday that trials of experimental coronavirus vaccines involving ... World News
